Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT05877326
Other study ID # 2022-A02200-43
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date September 2023
Est. completion date May 10, 2025

Study information

Verified date June 2023
Source Centre Cardiologique du Nord
Contact Ellouze Omar, MD
Phone 0149337245
Email ellouze.omar@yahoo.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Postoperative delirium (POD) is a critical complication of major surgery and affects up to 70% of surgical patients over the age of 60 years. The additional healthcare costs associated with delirium exceed €50,000 per patient per year due to prolonged hospital stay, increased risk of long-term care or institutionalization, and the risk of developing dementia or cognitive impairment . Therefore, prevention of POD is a major goal in the perioperative setting. The investigator proposes this randomized study to evaluate the interest of a reduced anesthetic depth to prevent short-term cognitive disorders after cardiac surgery in elderly subjects. Method: Patients over 75 years old scheduled to undergo one of the cardiac surgeries of interest (valvular, coronary bypass, aortic or combined surgery) will be randomized to 2 paralell arms : - Perioperative anesthesia with a BIS (Bispectral index) target of 35 - Perioperative anesthesia with a BIS(Bispectral index) target of 55 The presence of mental confusion will be determined by CAM-ICU ( Confusion Assessment Method for the ICU ) at day 3 post procedure. Ancillary study: To assess cognitive status at inclusion, discharge and third post operative month using the MOCA(Montreal Cognitive Assessment ). Conclusion:The hypothesis of this study is that a lower depth of anesthesia will reduce post operative delirium in the first three days in patients older than 75 years who are planned for valvular, coronary artery bypass, aortic or combined cardiac surgery .


Description:

Multicenter, controlled, randomized trial with two parallel arms (Perioperative anesthesia with a BIS target of 35 / Perioperative anesthesia with a BIS target of 55). Randomization will be stratified by center, type of surgery (valve vs coronary artery bypass surgery vs aortic surgery vs combined surgery), patient age (75-80 vs 81-85), Euroscore 2 score at inclusion (predicted mortality risk ≥ vs < to 30%). An ancillary study with MOCA score measurement at inclusion, discharge and 3 months after cardiac surgery will be realized. Primary Objective: To demonstrate the benefit of lower anesthesia on the prevalence of delirium during the first 3 days postoperatively in patients aged 75 years and older having cardiac surgery (valvular, coronary bypass, aortic or combined surgery). Primary endpoint: Presence of mental confusion will be determined by CAM-ICU at day 3 post surgery. The CAM-ICU is considered POSITIVE (confusion present) if criteria 1 and 2 + 3 or 4 are met. Secondary objectives: To evaluate the effects of the intervention on ICU and hospital length of stay, delirium durations, mortality at month 3 , prevalence of POD during the stay, duration of mechanical ventilation, rate of reintubation,total amount of propofol, opioids and neuromuscular blockade (au lieu de curares) during anesthesia . Secondary endpoints: CAM ICU at times day 1, Day 2 , and Day 3 , daily doses of benzodiazepines, opiates, propofol, dexmedetomidine, and neuroleptics, days without mechanical ventilation, ICU and total lengths of stay, vital status (phone call) at Month 3, duration of delirium, total amount of propofol, opioids and neuromuscular blockade during anesthesia . In order to demonstrate a minimum difference in the confounding rate (according to CAM-ICU) of 20 points (50% expected in the BIS 35 arm versus 30% in the BIS 55 arm) and with a two-sided first-species risk of 5% and a minimum power of 80%, 186 analyzable subjects (93 per arm) are required. In order to take into account possible loss of sight, we propose to include in this study a total of 200 subjects (100 per arm).


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 200
Est. completion date May 10, 2025
Est. primary completion date May 10, 2025
Accepts healthy volunteers No
Gender All
Age group 75 Years to 85 Years
Eligibility Inclusion Criteria: - Patient aged between 75 and 85 years, who signed an informed consent, undergoing elective valvular, coronary artery bypass, aortic or combined cardiac surgery - Be affiliated to French Health Insurance Exclusion Criteria: - Refusal of consent -Patient unable to read, write or understand French - Vulnerable patient according to article L1121-6 of the CSP, - Patient of legal age under guardianship or curatorship or under legal protection, - Patient unable to give personal consent according to article L.1121-8 of the CSP or adult protected by law, - Patient having already participated in the present study

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
General anesthesia with propofol or sevoflurane
General anesthesia
Behavioral:
CAM-ICU (Confusion Assesment Method ICU) at day 3 post-operative
The presence of mental confusion will be determined by CAM-ICU at J3 post intervention.

Locations

Country Name City State
France Centre cardiologique du nord Saint-Denis

Sponsors (1)

Lead Sponsor Collaborator
Centre Cardiologique du Nord

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary To demonstrate the benefit of reduced depth of anesthesia The presence of mental confusion using CAM-ICU ( The Confusion Assessment Method for the Intensive Care Unit ) Day 3 post intervention.
See also
  Status Clinical Trial Phase
Recruiting NCT06028126 - Superficial Parasternal Intercostal Plane Block in Cardiac Surgery Trial N/A
Terminated NCT00991328 - Role of Absolute Cerebral Oximetry to Prevent Neurocognitive Injury in Elderly Patients Undergoing Cardiac Surgery Phase 3
Active, not recruiting NCT03785158 - MIND After Surgery N/A
Recruiting NCT06236854 - Neuroimaging Risk of Postoperative Delirium
Completed NCT00250237 - Post-operative Haloperidol Versus Placebo for Prevention of Post-operative Delirium After Acute Hip Surgery Phase 3
Completed NCT03953313 - Risk Communication About Post-operative Delirium (POD) and Post-operative Cognitive Dysfunction (POCD)
Recruiting NCT05887076 - Postoperative Delirium After Kidney Transplantation
Recruiting NCT05777187 - Mitigation of Postoperative Delirium in High-Risk Patients N/A
Recruiting NCT05688449 - Effect of Epidural Analgesia on Burst Suppression Phase 4
Completed NCT00791648 - Short-term Atorvastatin's Effect on Acute Kidney Injury Following Cardiac Surgery N/A
Completed NCT03132168 - Postoperative Delirium in Patients Undergoing Radical Cystectomy N/A
Completed NCT02692300 - EEG Guidance of Anesthesia (ENGAGES-CANADA) N/A
Completed NCT02325154 - Cerebral Oxygenation in Total Hip Arthroplasty Patients N/A
Active, not recruiting NCT01993992 - Parental Anxiety and Its Relationship With Pediatric Patients' Post-operative Responses N/A
Completed NCT00865202 - A Placebo Controlled Trial Of L-Tryptophan In Post-Operative Delirium Phase 3
Completed NCT05159648 - A Study to Evaluate ICU Simulation Experience in the Cardiothoracic Surgical Population to Reduce Post-operative Delirium
Completed NCT01561378 - Cardiac Surgery Neuroprotection Study in Elders Phase 2
Recruiting NCT06036095 - Total Intravenous Versus Inhalational Anesthesia- A Geriatric Anesthesia Study Phase 4
Completed NCT03053869 - Benzodiazepine-free Anesthetic for Reduction of Delirium (B-Free) Phase 1